AVXL Anavex Life Sciences Corp.
Healthcare$2.65+0.00%OpenMarket Cap: $246.0M
As of 2026-05-26
Insider Statistics (Q4 2025)
Acquisitions
2
Dispositions
0
Buy/Sell Ratio
0.00
Net Shares
+137,500
Shares Acquired
137,500
Shares Disposed
0
Total Bought ($)
$0.00
Total Sold ($)
$0.00
Recent Insider Trades
| Filing Date | Name | Type | Action | Shares | Price | Shares After |
|---|---|---|---|---|---|---|
| Thu May 14 | Kellmeyer Terrie | officer: Interim CEO | Sell | 50,000 | $8.58 | 0 |
| Thu May 14 | Kellmeyer Terrie | officer: Interim CEO | Sell | 46,668 | $7.21 | 0 |
| Thu May 14 | Kellmeyer Terrie | officer: Interim CEO | Sell | 7,500 | $5.36 | 0 |
| Fri May 01 | Paeger Axel | director: | Sell | 0 | $0.00 | 0 |
| Fri Jan 09 | MISSLING CHRISTOPHER U | director, officer: President and CEO | Sell | 125,000 | $8.58 | 125,000 |
| Fri Jan 09 | Boenisch Sandra | officer: PFO & Treasurer | Sell | 12,500 | $8.58 | 12,500 |
| Fri Oct 03 | MISSLING CHRISTOPHER U | director, officer: President and CEO | Sell | 125,000 | $5.36 | 250,000 |
| Fri Oct 03 | Boenisch Sandra | officer: PFO & Treasurer | Sell | 12,500 | $5.36 | 25,000 |
| Fri Sep 12 | MISSLING CHRISTOPHER U | director, officer: President and CEO | Sell | 187,500 | $5.04 | 1,655,213 |
| Fri Sep 12 | MISSLING CHRISTOPHER U | director, officer: President and CEO | Sell | 145,048 | $9.58 | 1,510,165 |
| Fri Aug 22 | MISSLING CHRISTOPHER U | director, officer: President and CEO | Sell | 125,000 | $8.58 | 125,000 |
| Fri Aug 22 | Boenisch Sandra | officer: PFO & Treasurer | Sell | 12,500 | $8.58 | 12,500 |
| Mon Jun 09 | Thomas Steffen | director | Sell | 50,000 | $1.76 | 55,000 |